GFAP and neuromyelitis optica: Taken together, E5415A-injected rats exhibited NMO-like pathological manifestations of ON, including the loss of AQP4/GFAP immunoreactivity, macrophage and neutrophil infiltration, demyelination, and axonal degeneration.